Debra MacCuaig, 38, from Glasgow, noticed she was looking particularly tanned, but put this down to her increased use of fake ...
Zanidatamab, a bispecific HER2-targeted antibody, delivered clinically meaningful and durable responses for patients with HER2-positive biliary tract cancer (BTC), according to final results from the ...
Zanidatamab, a bispecific HER2-targeted antibody, delivered clinically meaningful and durable responses for patients with HER2-positive biliary tract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results